Cite
TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling
MLA
Ester Pagano, et al. “TRPM8 Indicates Poor Prognosis in Colorectal Cancer Patients and Its Pharmacological Targeting Reduces Tumour Growth in Mice by Inhibiting Wnt/β-Catenin Signalling.” British Journal of PharmacologyREFERENCES, vol. 180, no. 2, July 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ea5ddacf9af492cbde6bb3ea7d4908da&authtype=sso&custid=ns315887.
APA
Ester Pagano, Barbara Romano, Donatella Cicia, Fabio A. Iannotti, Tommaso Venneri, Giuseppe Lucariello, Maria Francesca Nanì, Fabio Cattaneo, Paola De Cicco, Maria D’Armiento, Marcello De Luca, Ruggiero Lionetti, Stefania Lama, Paola Stiuso, Pietro Zoppoli, Geppino Falco, Silvia Marchianò, Stefano Fiorucci, Raffaele Capasso, … Angelo A. Izzo. (2022). TRPM8 indicates poor prognosis in colorectal cancer patients and its pharmacological targeting reduces tumour growth in mice by inhibiting Wnt/β-catenin signalling. British Journal of PharmacologyREFERENCES, 180(2).
Chicago
Ester Pagano, Barbara Romano, Donatella Cicia, Fabio A. Iannotti, Tommaso Venneri, Giuseppe Lucariello, Maria Francesca Nanì, et al. 2022. “TRPM8 Indicates Poor Prognosis in Colorectal Cancer Patients and Its Pharmacological Targeting Reduces Tumour Growth in Mice by Inhibiting Wnt/β-Catenin Signalling.” British Journal of PharmacologyREFERENCES 180 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ea5ddacf9af492cbde6bb3ea7d4908da&authtype=sso&custid=ns315887.